August 27, 2021
Targovax ASA: Abstract on ONCOS-102 phase 1 trial in advanced PD1 refractory melanoma is accepted at ESMO Congress
Media
August 27, 2021
Vicore strengthens its management team
August 27, 2021
Nordic Nanovector ASA: Results for the Second Quarter and First Half 2021
August 26, 2021
Interim report April – June 2021
August 25, 2021
Spruce Biosciences Announces Pediatric Classic CAH Program Details During Virtual R&D Day
August 20, 2021
Oncopeptides publishes report for Q2 2021
August 18, 2021
Targovax ASA: second quarter and first half year 2021 results
August 17, 2021
Precirix enters into alliance with 3P Biopharmaceuticals for the manufacturing of single domain antibodies
August 12, 2021
VTX-801 Receives U.S. FDA Fast Track Designation for the Treatment of Wilson Disease
August 12, 2021
Fusion Pharmaceuticals And TRIUMF Announce Expanded R&D Collaboration For Actinium Supply Production